Skip to content

Infection with harmless hepatitis G doesn't mean that HIV treatment works better

UK HIV patients have high levels of primary drug resistance

Some groups get more benefit from anti-HIV drugs than others

Poor immmunologic response to HAART should be cause for concern in viral load responders

High incidence of TB after ART started, MSF reports

Unstable work and lack of partner increase risk of hospitalisation in early years of HIV infection, even with HAART

CD4 percentage could help decide when to start treatment

Large study proves that HAART reduces rates of AIDS and death

Gilead reports problems putting tenofovir, FTC and efavirenz into one pill